Arvind Chavali

ZS Associates


4 Key Actions ClinOps Can Take Now to Avoid Disruptions

April 02, 2020

Biopharmaceutical sponsors should make urgent decisions now to plan for continued clinical research in the coming months.

How Pharma Can Work with the FDA to Embrace Innovation and Overcome Its “Adoptaphobia”

March 25, 2019

FDA commissioner Scott Gottlieb criticized pharmaceutical companies and clinical research organizations for being slow to adapt innovations in clinical research, claiming that the business model adopted just isn’t compatible with the kind of changes that certain innovations can enable.